SPECTRUM PHARMACEUTICALS

×

Error message

  • Notice: Trying to get property 'tid' of non-object in eval() (line 35 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Trying to get property 'name' of non-object in eval() (line 35 of /var/www/7/modules/php/php.module(80) : eval()'d code).

Associated tags: Spectrum, Medication, Spectrum Pharmaceuticals, SPPI, Pharmaceutical industry, Safety, Patient, FDA, Complaint, Health

Locations: UNITED STATES, NORTH AMERICA, , MASSACHUSETTS

Spectrum Pharmaceuticals to Report Third Quarter 2022 Financial Results and Provide Corporate Update

Retrieved on: 
Thursday, November 3, 2022

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the third quarter 2022 financial results and provide a corporate update on Thursday, November 10, 2022, at 4:30 p.m. Eastern/1:30 p.m. Pacific.

Key Points: 
  • Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the third quarter 2022 financial results and provide a corporate update on Thursday, November 10, 2022, at 4:30 p.m. Eastern/1:30 p.m. Pacific.
  • Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies.
  • SPECTRUM PHARMACEUTICALS, INC. is a registered trademark of Spectrum Pharmaceuticals, Inc and its affiliate.
  • REDEFINING CANCER CARE and the Spectrum Pharmaceuticals logos are trademarks owned by Spectrum Pharmaceuticals, Inc. Any other trademarks are the property of their respective owners.